Logos Global Management LP Q4 2019 Filing
Filed February 14, 2020
Portfolio Value
$405.7B
Holdings
38
Report Date
Q4 2019
Filing Type
13F-HR
All Holdings (38 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRTXEURMIRATI THERAPEUTICS INC | 663,660 | $85.5B | 21.08% | Put |
| 2 | SRPTSAREPTA THERAPEUTICS INC | 226,002 | $29.2B | 7.19% | |
| 3 | ASNDASCENDIS PHARMA A S | 179,898 | $25.0B | 6.17% | |
| 4 | AMRNAMARIN CORP PLC | 962,553 | $20.6B | 5.09% | |
| 5 | APLSAPELLIS PHARMACEUTICALS INC | 587,108 | $18.0B | 4.43% | |
| 6 | —BLUEBIRD BIO INC | 204,420 | $17.9B | 4.42% | |
| 7 | —ZYMEWORKS INC | 389,153 | $17.7B | 4.36% | |
| 8 | —MYOKARDIA INC | 231,009 | $16.8B | 4.15% | |
| 9 | —ZOGENIX INC | 287,024 | $15.0B | 3.69% | |
| 10 | XLRNACCELERON PHARMA INC | 267,676 | $14.2B | 3.50% | |
| 11 | SG7SAGE THERAPEUTICS INC | 190,150 | $13.7B | 3.38% | |
| 12 | AXSMAXSOME THERAPEUTICS INC | 124,937 | $12.9B | 3.18% | |
| 13 | RETAEURREATA PHARMACEUTICALS INC | 55,700 | $11.4B | 2.81% | |
| 14 | —BIOHAVEN PHARMACTL HLDG CO L | 187,242 | $10.2B | 2.51% | |
| 15 | BMY-RBRISTOL MYERS SQUIBB CO | 3,322,816 | $10.0B | 2.47% | |
| 16 | QUREUNIQURE NV | 138,425 | $9.9B | 2.45% | |
| 17 | CCXIEURCHEMOCENTRYX INC | 186,238 | $7.4B | 1.82% | |
| 18 | —KADMON HLDGS INC | 1,350,351 | $6.1B | 1.51% | |
| 19 | IOVAIOVANCE BIOTHERAPEUTICS INC | 220,543 | $6.1B | 1.50% | |
| 20 | SWTXSPRINGWORKS THERAPEUTICS INC | 134,397 | $5.2B | 1.28% | |
| 21 | RCKTROCKET PHARMACEUTICALS INC | 223,337 | $5.1B | 1.25% | |
| 22 | —CONSTELLATION PHARMCETICLS I | 101,050 | $4.8B | 1.17% | |
| 23 | —MOLECULAR TEMPLATES INC | 339,900 | $4.8B | 1.17% | |
| 24 | OPHTEURIVERIC BIO INC | 523,462 | $4.5B | 1.11% | |
| 25 | 1K0IGM BIOSCIENCES INC | 114,411 | $4.4B | 1.08% | |
| 26 | ASMBASSEMBLY BIOSCIENCES INC | 188,000 | $3.8B | 0.95% | |
| 27 | BLUBELLUS HEALTH INC NEW | 424,618 | $3.2B | 0.80% | |
| 28 | KRTXKARUNA THERAPEUTICS INC | 39,647 | $3.0B | 0.74% | |
| 29 | —APTOSE BIOSCIENCES INC | 523,803 | $3.0B | 0.73% | |
| 30 | MEIPUSDMEI PHARMA INC | 1,145,528 | $2.8B | 0.70% | |
| 31 | MDGLMADRIGAL PHARMACEUTICALS INC | 27,279 | $2.5B | 0.61% | |
| 32 | YB4PSAVARA INC | 613,999 | $2.5B | 0.61% | |
| 33 | ETNBGBP89BIO INC | 86,591 | $2.3B | 0.56% | |
| 34 | FULCFULCRUM THERAPEUTICS INC | 123,635 | $2.1B | 0.51% | |
| 35 | NERVGBPMINERVA NEUROSCIENCES INC | 227,835 | $1.6B | 0.40% | |
| 36 | ARDXARDELYX INC | 212,449 | $1.6B | 0.39% | |
| 37 | —NEOLEUKIN THERAPEUTICS INC | 40,529 | $499.0M | 0.12% | |
| 38 | KZRKEZAR LIFE SCIENCES INC | 122,931 | $493.0M | 0.12% |